🔗 Permalink

Inventor profile of:

Gary L. Olson

City:

Mountainside, New Jersey

Country:

United States

Published Applications:

Last publication date:

2026-03-19

Top Assignees for applications by Gary L. Olson

The entities that hold a legal rights for patent applications filed by inventor Olson Gary L.:

Praecis Pharmaceuticals, Inc. 11 Waltham, MA United States
SUPERNUS PHARMACEUTICALS, INC. 6 Rockville, MD United States
PALATIN TECHNOLOGIES, INC. 1 Cranbury, NJ United States
Albert Einstein College of Medicine of Yeshiva University 1 Bronx, NY United States
Praecis Pharmaceuticals Incorporated 1 Waltham, MA United States

Recent patent applications by Olson Gary L.

Gary L. Olson from Mountainside, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-03-19

US20260078098A1

Chemistry; metallurgy

PROCESS OF MAKING DERIVATIVES OF SUBSTITUTED MORPHOLINES

#2 | 2026-01-29

US20260028340A1

Chemistry; metallurgy

SUBSTITUTED DERIVATIVES OF ISOINDOLES

#3 | 2025-06-19

US20250197412A1

Chemistry; metallurgy

SUBSTITUTED DERIVATIVES OF ISOINDOLES

#4 | 2025-04-03

US20250108038A1

Human necessities

SUBSTITUTED DERIVATIVES OF ISOINDOLES AND USES THEREOF

#5 | 2024-05-16

US20240158439A1

Chemistry; metallurgy

INHIBITORS OF ANTIGEN PRESENTATION BY MHC CLASS II HLA-DRB1*15:01 MOLECULES WITH ENHANCED METABOLIC STABILITY

#6 | 2023-11-09

US20230357173A1

Chemistry; metallurgy

Process of making derivatives of substituted morpholines

#7 | 2023-09-21

US20230295100A1

Chemistry; metallurgy

PROCESS OF MAKING DERIVATIVES OF SUBSTITUTED MORPHOLINES

#8 | 2012-09-20

US20120238577A1

Human necessities

Prostaglandin transporter inhibitors and uses thereof

#9 | 2011-09-08

US20110217324A1

Chemistry; metallurgy

INHIBITORS OF ANTIGEN PRESENTATION BY MHC CLASS II MOLECULES AND METHODS OF USE THEREOF

#10 | 2011-07-21

US20110178080A1

Human necessities

Melanocortin receptor-specific spiro-piperidine compounds

#11 | 2009-06-18

US20090156624A1

Chemistry; metallurgy

Methionine aminopeptidase-2 inhibitors and methods of use thereof

#12 | 2007-07-12

US20070161570A1

Human necessities

Methionine aminopeptidase-2 inhibitors and methods of use thereof

#13 | 2007-05-24

US20070117758A1

Chemistry; metallurgy

Therapeutic agents and methods of use thereof for the modulation of angiogenesis

#14 | 2007-01-11

US20070010452A1

Human necessities

Methionine aminopeptidase-2 inhibitors and methods of use thereof

#15 | 2006-10-05

US20060223758A1

Human necessities

Therapeutic agents and methods of use thereof for the treatment of melanoma

#16 | 2006-08-01

US10001945

Therapeutic agents and methods of use thereof for the modulation of angiogenesis

#17 | 2006-05-02

US9972772

Therapeutic agents and methods of use thereof for the modulation of angiogenesis

#18 | 2006-03-30

US20060069028A1

Human necessities

Therapeutic agents and methods of use thereof for the modulation of angiogenesis

#19 | 2005-07-19

US10138935

Therapeutic agents and methods of use thereof for the modulation of angiogenesis

#20 | 2005-06-16

US20050130903A1

Chemistry; metallurgy

Therapeutic agents and methods of use thereof for the modulation of angiogenesis

#21 | 2005-03-17

US20050059585A1

Human necessities

Methionine aminopeptidase-2 inhibitors and methods of use thereof

InventorID:

3259872 ⎘